Clinical Trial Update: 6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing asenapine with placebo in adults with acute exacerbation of schizophrenia; the study was completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Saphris (asenapine)

Snippet

Sponsor: Organon and Co | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2015-04-17